<DOC>
	<DOC>NCT01797562</DOC>
	<brief_summary>To evaluate the performance and safety of seven T.R.U.E. Test Panel allergens in subjects 6-17 years of age with suspected contact dermatitis.</brief_summary>
	<brief_title>Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents</brief_title>
	<detailed_description>To evaluate the diagnostic performance (primary) and safety (secondary) of seven T.R.U.E. Test Panel allergens; Gold sodium thiosulfate, Hydrocortisone-17-butyrate, Bacitracin, Parthenolide, Methyldibromoglutaronitrile, Disperse blue 106, and Bronopol in pediatric subjects 6-17 years of age with suspected contact dermatitis based on symptoms and clinical history.</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Contact</mesh_term>
	<mesh_term>Dermatitis, Allergic Contact</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Parthenolide</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Sodium thiosulfate</mesh_term>
	<mesh_term>Bacitracin</mesh_term>
	<mesh_term>Bronopol</mesh_term>
	<mesh_term>Gold Sodium Thiosulfate</mesh_term>
	<mesh_term>Hydrocortisone-17-butyrate</mesh_term>
	<criteria>Symptoms and history potentially consistent with allergic contact dermatitis Children and adolescents 617 years of age, in general good health Adolescent females 15 years of age or older (or with menarche) must consent to a urine pregnancy test; urine test results must be negative for study inclusion Informed consent must be signed and understood by subject. If underage, informed consent must be signed and understood by parent or legal guardian, consistent with all institutional, local and national regulations Topical corticosteroid treatment during the last 7 days on or near the test area. Systemic treatment with corticosteroids or other immunosuppressives during the last 7 days. Subjects currently receiving (or received during the previous 3 weeks) other investigational drugs, treatments or devices, or participating in another clinical study Treatment with ultraviolet (UV) light (including tanning) during the previous 3 weeks Acute dermatitis outbreak or dermatitis on or near the test area on the back Subjects unable to comply with activity restrictions (e.g. protecting test panels from excess moisture due to showering or vigorous activity) Subjects unable or unwilling to comply with multiple return visits Female subjects 15 years of age (or with onset of menarche) and older unable to consent to a urine pregnancy test, or those with a positive pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Contact dermatitis</keyword>
	<keyword>Eczema</keyword>
</DOC>